Report cover image

Dermatologicals in Poland

Publisher Euromonitor International
Published Oct 15, 2024
Length 25 Pages
SKU # EP19272692

Description

Dermatologicals in Poland


Dermatologicals in Poland are expected to register minimal constant value growth in 2024, with volume sales also falling across many product areas. Topical antifungals, as well as nappy (diaper) rash treatments, continue to account for most value sales, but cold sore treatments, as well as hair loss treatments are expected to register the highest volume growth in 2024. Hair loss treatments is an emerging sector, with plenty of room for further growth. Increasingly men are becoming more conscious...

Euromonitor International's Dermatologicals in Poland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

25 Pages
Dermatologicals in Poland
Euromonitor International
October 2024
List Of Contents And Tables
DERMATOLOGICALS IN POLAND
KEY DATA FINDINGS
2024 DEVELOPMENTS
Minimal constant value growth in 2024
Competitive landscape remains diverse with players focusing on their own areas of expertise
Ageing population and climate change support growth 
PROSPECTS AND OPPORTUNITIES
Branded dermatologicals set to prevail over generics due to perceived efficacy and format innovations
Canesten makes mark in vaginal antifungals
Multifunctionality of Bepanthen continues to support growth
CATEGORY DATA
Table 1 Sales of Dermatologicals by Category: Value 2019-2024
Table 2 Sales of Dermatologicals by Category: % Value Growth 2019-2024
Table 3 NBO Company Shares of Dermatologicals: % Value 2020-2024
Table 4 LBN Brand Shares of Dermatologicals: % Value 2021-2024
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2021-2024
Table 6 Forecast Sales of Dermatologicals by Category: Value 2024-2029
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2024-2029
CONSUMER HEALTH IN POLAND
EXECUTIVE SUMMARY
Consumer health in 2024: The big picture
2024 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
Table 9 Life Expectancy at Birth 2019-2024
MARKET DATA
Table 10 Sales of Consumer Health by Category: Value 2019-2024
Table 11 Sales of Consumer Health by Category: % Value Growth 2019-2024
Table 12 NBO Company Shares of Consumer Health: % Value 2020-2024
Table 13 LBN Brand Shares of Consumer Health: % Value 2021-2024
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
Table 15 Distribution of Consumer Health by Format: % Value 2019-2024
Table 16 Distribution of Consumer Health by Format and Category: % Value 2024
Table 17 Forecast Sales of Consumer Health by Category: Value 2024-2029
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us